NCT01119781View on ClinicalTrials.gov

A Single-Dose, Pharmacokinetic/Pharmacodynamic (PK/PD), & Safety Study of BIIB017 in Participants With Renal Impairment & Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions

HealthyRenal Insufficiency

Interventions

DRUG

BIIB017(peginterferon beta-1a)

peginterferon beta-1a administered by a single subcutaneous (SC) injection using a pre-filled syringe on Day 1 at a dose of either 63 or 125 mcg depending on subpopulation assignment reflecting whether a healthy volunteer or level of renal impairment.